Skip to main content
SpringerLink
Log in

Menopause

Auf gutem Weg durch die Wechseljahre

Menopause

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Zusammenfassung

Reproduktives Altern und Menopause werden aus der gesellschaftlichen Wahrnehmung immer noch weitgehend ausgeblendet und stattdessen wird ein Bild dauerhaft junger, aktiver und fruchtbarer Frauen gezeichnet. Umso belastender sind der Verlust der Fertilität, das Altern und der Beginn einer anderen Lebensphase für viele Frauen, zumal sie sich oft mit diesen Themen alleingelassen fühlen. Ergreifen Sie die Gelegenheit und sprechen Sie mit Ihren betroffenen Patientinnen!

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 1
Abb. 2
Abb. 3

Literatur

  1. de Bruin JP, Bovenhuis H, van Noord PA et al. The role of genetic factors in age at natural menopause. Hum Reprod. 001;16:2014–18

  2. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol. 1998;8:229–35

    Article  CAS  Google Scholar 

  3. Wise AM, Krajnak KM, Kashon ML. Menopause: the aging of multiple pacemakers. Science. 1996;273:67–70

    Article  CAS  Google Scholar 

  4. Snowdon DA, Kane RL, Besson WL et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health. 1989;79:709–14

    Article  CAS  Google Scholar 

  5. Stanford L, Hartge P, Brinton LA et al. Factors influencing the age at natural menopause. J Chronic Dis. 1987;40:995–1002

    Article  CAS  Google Scholar 

  6. van Noord PA, Dubas JS, Dorland M et al. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril. 1997;68:95–102

    Article  CAS  Google Scholar 

  7. Ahuja M. Age of menopause and determinants of menopause age: a PAN India survey by IMS. J Midlife Health. 2016;7:126–31

    PubMed  PubMed Central  Google Scholar 

  8. Turner G, Robinson H, Wake S et al. Dizygous twinning and pre-mature menopause in fragile X syndrome. Lancet. 1994;344:1500

    Article  CAS  Google Scholar 

  9. Conway GS, Hettiarachchi S, Murray A et al. Fragile X permutations in familial premature ovarian failure. Lancet. 1995;346:309–10

    Article  CAS  Google Scholar 

  10. Burger HG, Dudley EC, Robertson DM et al. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257–75

    Article  CAS  Google Scholar 

  11. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril. 1999;71:658–62

    Article  CAS  Google Scholar 

  12. Santoro N, Lasley B, McConnell D et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the study of women’s health across the nation (SWAN) daily hormone study. J Clin Endocrinol Metab. 2004;89:2622–31

    Article  CAS  Google Scholar 

  13. Santoro N, Brown JR, Adel T et al. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996;81:1495–1501

    CAS  PubMed  Google Scholar 

  14. JF Randolph Jr, Zheng H, MR Sowers et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2011;96:746–54

    Article  CAS  Google Scholar 

  15. Santoro N. Using antimullerian hormone to predict fertility. JAMA. 2017;318:1333–4

    Article  Google Scholar 

  16. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of reproductive aging workshop (STRAW). Fertil Steril. 2001;76:874–8

    Article  CAS  Google Scholar 

  17. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97:1159–68

    Article  CAS  Google Scholar 

  18. Stuenkel CA, Davis SR, Gompel A et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011

    Article  CAS  Google Scholar 

  19. Gallicchio L, Miller SR, Kiefer J et al. Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the midlife women’s health study. Menopause. 2015;22:1098–1107

    Article  Google Scholar 

  20. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6:2133–42

    Article  Google Scholar 

  21. Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin North Am. 2011;38:567–86

    Article  Google Scholar 

  22. Bromberger JT, Kravitz HM. Mood and men-opause: findings from the study of women’s health across the nation (SWAN) over 10 years. Obstet Gynecol Clin North Am. 2011;38:609–25

    Article  Google Scholar 

  23. Cohen LS, Soares CN, Vitonis AF et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385–90

    Article  Google Scholar 

  24. Freeman EW, Sammel MD, Lin H et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63:375–82

    Article  CAS  Google Scholar 

  25. van Voorhis BJ, Santoro N, Harlow S et al. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol. 2008;112:101–8

    Article  Google Scholar 

  26. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175:531–9

    Article  Google Scholar 

  27. Sarrel P1, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015;22:260–6

    Article  Google Scholar 

  28. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O’Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12

    Article  CAS  Google Scholar 

  29. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA.2002;288:321–33

    Article  CAS  Google Scholar 

  30. Gesundheitsreport der Techniker Krankenkasse 2011

  31. Rossouw JE1, Manson JE, Kaunitz AM, Anderson GL. Lessons learned from the Women’s Health Initiative trials of menopausal hormone therapy. Obstet Gynecol. 2013;121:172–6

    Article  Google Scholar 

  32. Manson JE, Kaunitz AM. Menopause management — Getting clinical care back on track. N Engl J Med. 2016;374:803–6

    Article  Google Scholar 

  33. Santen RJ, Stuenkel CA, Burger HG, Manson JE. Competency in menopause management: whither goest the internist? J Womens Health 2014;23:281–5

    Article  Google Scholar 

  34. Mueck AO. Anwendungsempfehlungen zur Hormonsubstitution im Klimakterium und Postmenopause. Frauenarzt 2015;56:657–9

    Google Scholar 

  35. Bassuk SS, Manson JE. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset? Metabolism. 2016;65:794–803

    Article  CAS  Google Scholar 

  36. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradioltesting the menopausal hormone timing hypothesis. Menopause. 2015;22:391–401

    Article  Google Scholar 

  37. Olié V, Canonico M, Scarabin PY. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol. 2010;17:457–63

    Article  Google Scholar 

  38. Sweetland S, Beral V, Balkwill A et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J. Thromb. Haemost. 2012;10:2277–86

    Article  CAS  Google Scholar 

  39. Birkhaeuser M, Hadji P, Imthurn B, Mueck AO, Neulen J, Thaler CJ, Wiegratz I, Wildt L. Postmenopausale Hormonsubstitution und Thrombo-Embolierisiko: Unterschied zwischen oraler und transdermaler Applikation? Gyne 2014

  40. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–11

    Article  CAS  Google Scholar 

  41. Asi N, Mohammed K, Haydour Q, Gionfriddo MR, Vargas OL, Prokop LJ, Faubion SS, Murad MH. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Syst Rev. 2016;26:121

    Article  Google Scholar 

  42. Kharode Y, Bodine PV, Miller CP et al. The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology. 2008;149:6084–91

    Article  CAS  Google Scholar 

  43. Komm BS, Mirkin S. Evolution of the tissue selective estrogen complex (TSEC). J Cell Physiol}. 2013;228:1423–27

    Article  CAS  Google Scholar 

  44. Stefanopoulou E, Grunfeld EA. Mind-body interventions for vasomotor symptoms in healthy menopausal women and breast cancer survivors. A systematic review. J Psychosom Obstet Gynaecol. 2017;38(:210–25

    Article  Google Scholar 

  45. Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-LaForce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW, Cohen LS, Joffe H, Anderson GL, Larson JC, Hunt JR, Ensrud KE, LaCroix AZ. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause. 2014;21:339–46

    PubMed  PubMed Central  Google Scholar 

  46. Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-LaForce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE, Freeman EW, Hunt JR, Joffe H, Larson JC, Learman LA, Rothenberg R, Seguin RA, Sherman KJ, Sternfeld BS, LaCroix AZ. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol. 2014;210:244, e1-11

    Article  Google Scholar 

  47. Broekmans FJ, Soules MR, Fauser BC. Ovarian Aging: Mechanisms and Clinical Consequences. Endocrine Reviews. 2009;30:465–93

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hormon- und Kinderwunschzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig Maximilians Universität München, Campus Innenstadt, Maistrasse 11, D-80337, München, Deutschland

    Corinna Mann

  2. Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität München, München, Deutschland

    Sven Mahner &  Christian J. Thaler

Authors
  1. Corinna Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sven Mahner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian J. Thaler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corinna Mann.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Sie legen folgende potenzielle Interessenkonflikte offen: Frau Dr. Mann: Unterstützung der Firma medimove GmbH bei der Entwicklung der Menopausen-App mimeno. Prof. Mahner: Unterstützung bei Forschungsprojekten, Advisory Boards, Honorar und Reisekostenübemahme seitens Astra-Zeneca, Clavis, Medac, MSD, Novartis, OLYMPUS Europa, PharmaMar, Roche, Sensor Kinesis, Tesaro, Teva. Prof. Thaler: Honorare und/oder Unterstützung für die Teilnahme an Kongressen von den Firmen MSD, Gedeon Richter, Novo Nordisk, Jenapharm, Bayer Healthcare, Gerring und Aristo.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mann, C., Mahner, S. & Thaler, C.J. Auf gutem Weg durch die Wechseljahre. MMW - Fortschritte der Medizin 161, 50–57 (2019). https://doi.org/10.1007/s15006-019-0004-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-019-0004-z

Keywords

Search

Navigation